Next Generation Sequencing Market - Size,
Share, and Forecast 2025
Next Generation Sequencing (NGS) is a powerful, flexible, and indispensable biological tool that
is used in several areas of biological study. NGS technologies help in generating genome-wide
sequence data in a couple of days. These technologies are highly parallelized allowing to
sequence thousands to millions of molecules at the same time. The main advantage of these
platforms is determination of the sequenced data from amplified single DNA fragments, avoiding
the need for cloning of DNA fragments.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/158
NGS has large number of applications, enabling rapid technological advances across several
fields in biological science. The technology has enabled researchers to gain significant
knowledge in public health studies and epidemiology, to sequence viruses and bacteria and help
detect causes that may contribute to virulence. Furthermore, in gene expression research, next
generation sequencing of RNA replace microarray analysis, allowing researchers to see RNA
expression sequence. This RNA sequencing can provide information on entire transcriptome in
one analysis, irrespective of any previous knowledge of genetic sequence.
The global next generation sequencing market was valued at US$ 5.6 billion in 2017 and is
expected to witness a robust CAGR of 18.1% over the forecast period (2017–2025).
Rising demand for early detection of cancer and infectious diseases to drive growth of the NGS
market
The chances of successful treatment increase when cancer and infectious diseases are detected at
the early stage. One of the major factors that drive growth of the next generation sequencing
market is the rising prevalence of cancer and other infectious diseases. According to the World
Health Organization (WHO), in 2012, new cases of cancer was around 14 million and the
incidence is estimated to increase to 70% by 2030.
As per statistics published by National Cancer Institute (NCI), in 2016, 1,685,210 new cases of
cancer were diagnosed in the U.S. alone. In 2015, WHO reported 8.8 million deaths occurred